Democratizing Diagnostic Testing for Preventable Diseases w/MainzBiomed CEO Guido Baechler

Improve Healthcare

Sisällön tarjoaa Dr. Rich Greenhill. Dr. Rich Greenhill tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.

1+ y ago 18:54

MP3•Jakson koti

Arkistoidut sarjat ("Toimeton syöte" status)

When? This feed was archived on August 06, 2023 21:08 (9M ago). Last successful fetch was on March 13, 2023 14:04 (1y ago)

Why? Toimeton syöte status. Palvelimemme eivät voineet hakea voimassa olevaa podcast-syötettä tietyltä ajanjaksolta.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Guido Baechler is CEO and Director at Mainz Biomed (NASDAQ: MYNZ) a leading developer of market-ready molecular genetic diagnostic solutions for life-threatening conditions. The Company's flagship product is ColoAlert, an accurate, non-invasive, and easy-to-use early detection test for colorectal cancer.

Guido has 30 years of global experience leading public & private life sciences companies having held senior executive roles at Singulex and SummerBio, and at Roche, where he led Roche Molecular’s global program management.

Learn more @MainzBiomed

74 jaksoa

#Fitness #Healthcare Delivery #Healthcare Quality #Healthcare Performance Improvement #Business #Medicine #Dr. Rich Greenhill